is zepbound a glp 1 medication Zepbound: The newest obesity explained by an expert Zepbound: The newest obesity medication
Description
#glp1 #diabetes #medication #T2DM | 28 comments on LinkedIn
It is currently in Phase 2 clinical trials for the treatment of overweight and obesity
A 2026 case report describes a 34-year-old man with obesity and alcohol use disorder whose semaglutide treatment for weight loss was associated with a marked drop in drinking over 10 months, with his AUDIT score falling from 27 to 7 and alcohol use dropping from about 15 drinks per week to half a beer per month
American Journal of Cardiology, Volume 222, 121 - 130
However, genetic variants can alter the response in some.
A Breakthrough Award, New Evidence in Parkinson's and Heart Disease
